awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35534349-27311776-F71D-4F39-BC2B-B51D666F5930
Q35534349-27311776-F71D-4F39-BC2B-B51D666F5930
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35534349-27311776-F71D-4F39-BC2B-B51D666F5930
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
P2860
Q35534349-27311776-F71D-4F39-BC2B-B51D666F5930
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35534349-27311776-F71D-4F39-BC2B-B51D666F5930
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70cdd9faae134df97d05cbf006950f7f13266d88
P2860
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer.